AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9498448
Drug: National Institute
RxNorm normalized name: vilanterol
DrugBank: Vilanterol (DB09082)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: National Institute of Public Health (Oslo) vaccine
Trial: 7849954
Drug: Perflubron emulsion
RxNorm normalized name: PERFLUBRON
DrugBank: Perflubron (DB05791)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perflubron emulsion (0.15 to 0.50 mL) administered by subcutaneous injection
Trial: 7849954
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of massage to the injection site
Trial: 3240893
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment with Ditropan 5 mg t.i.d. for 6 weeks prior to surgery (n = 21)
Trial: 3240893
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (n = 18) with no prior treatment for bladder instability
Trial: 3240893
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (n = 18)
Trial: 28473118
Drug: Continued thienopyridine
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued thienopyridine plus aspirin therapy for an additional 18 months
Trial: 18048857
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections of BoNT‐A (BOTOX 100 U total) and intraarticular injection of normal saline
Trial: 18048857
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection of TA (40 mg) and intramuscular injection of normal saline
Trial: 16863563
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) herbal formula containing 11 herbs
Trial: 12641502
Drug: Triple antibiotic
RxNorm normalized name: Triple Antibiotic
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triple antibiotic therapy (metronidazole 300 mg, clarithromycin 250 mg, and amoxicillin 500 mg, given four times daily for 2 weeks)
Trial: 15545314
Drug: Flurbiprofen microparticle
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen microparticle formulation (3.125 mg, 6.25 mg, 12.5 mg, 25 mg, or 50 mg)
Trial: 15545314
Drug: Flurbiprofen microparticle
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen microparticle formulation (12.5 mg and higher doses)
Trial: 2314826
Drug: Very-high-dose cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Very-high-dose cisplatin (40 mg/m2/day for 5 days)
Trial: 2314826
Drug: Standard-high-dose cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-high-dose cisplatin (either a single dose of 100 or 20 mg/m2/day for 5 days)
Trial: 303498
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of minocycline twice a day
Trial: 303498
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of minocycline twice a day
Trial: 18093505
Drug: Calendar reminder
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calendar reminder of medication taking
Trial: 17352866
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal treatment)
Trial: 11448321
Drug: 0.03% AGN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03% AGN 192024 once daily
Trial: 11448321
Drug: 0.003% AGN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.003% AGN 192024 once daily
Trial: 11448321
Drug: 0.01% AGN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01% AGN 192024 once daily
Trial: 11448321
Drug: 0.03% AGN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03% AGN 192024 twice daily
Trial: 10405567
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy with alteplase (r-TPA), aspirin, glyceryl trinitrate
Trial: 10405567
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy without reperfusion
Trial: 19545481
Drug: Waiting list
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting list for therapy
Trial: 25869840
Drug: Microdosing of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microdosing of (14)C-hRESCAP at 53 μg
Trial: 25869840
Drug: Therapeutic doses
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic doses of hRESCAP (up to 5.3 mg)
Trial: 21880193
Drug: Salmeterol/Fluticasone Propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/Fluticasone Propionate (SAL/FP) 50/250 μg, administered 2 inhalations BID for 2 weeks
Trial: 21880193
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate (FP) 250 μg, administered 2 inhalations BID for 2 weeks
Trial: 21880193
Drug: Salmeterol/Fluticasone Propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/Fluticasone Propionate (SAL/FP) 50/250 μg
Trial: 21880193
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate (FP) 250 μg
Trial: 15089806
Drug: Moxonidine 0.4
RxNorm normalized name: moxonidine 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine 0.4 mg orally
Trial: 9863079
Drug: Combined acupuncture-drug
RxNorm normalized name: antibiotics in combination with other drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined acupuncture-drug anesthesia (dolantin 25 mg and droperidol 2.5 mg administered intravenously, with acupuncture stimulation at Neiguan (P6) and Hegu (LI4) for 30 minutes).
Trial: 9863079
Drug: 5% procaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% procaine combined with drug anesthesia (control group).
Trial: 7868672
Drug: Reduced glutathione
RxNorm normalized name: Reduced glutathione
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced glutathione therapy
Trial: 3280220
Drug: Verapamil 80
RxNorm normalized name: verapamil 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 80 mg t.i.d. for one week
Trial: 3280220
Drug: Verapamil 120
RxNorm normalized name: verapamil 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 120 mg t.i.d. for one week
Trial: 3280220
Drug: Diltiazem 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 80 mg t.i.d. for one week
Trial: 3280220
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg t.i.d. for one week
Trial: 3280220
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of both drugs
Trial: 3280220
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of diltiazem
Trial: 30126709
Drug: Insulin-like growth
RxNorm normalized name: Insulin-like growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-like growth factor-1 (IGF-1)
Trial: 17393021
Drug: Enoxaparin 4,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 4,000 IU once daily
Trial: 17393021
Drug: Tinzaparin 4,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin 4,500 IU once daily
Trial: 12324912
Drug: Q(a) (reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q(a) (reduction of 1,000 mL/min)
Trial: 9807203
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy (tamoxifen) in postmenopausal patients
Trial: 9807203
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy (tamoxifen) in reproductive group
Trial: 7657415
Drug: Caffeine 0
RxNorm normalized name: caffeine 0.65 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 0 mg.kg body weight-1 (placebo)
Trial: 7657415
Drug: Caffeine 5
RxNorm normalized name: caffeine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 5 mg.kg body weight-1
Trial: 7657415
Drug: Caffeine 9
RxNorm normalized name: multivit,calcium,min/ferrous fum/folic acid/guarana/caffeine 9 mg iron-400 mcg-200 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 9 mg.kg body weight-1
Trial: 7657415
Drug: Caffeine 13
RxNorm normalized name: caffeine 13 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 13 mg.kg body weight-1
Trial: 2719903
Drug: Oral aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aqueous solution
Trial: 2719903
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release oral tablet (MST-Continus)
Trial: 2719903
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release buccal tablet
Trial: 27569351
Drug: Naftopidil 75
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 75 mg for 8 weeks
Trial: 27569351
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg and Solifenacin 5 mg for 8 weeks
Trial: 24844611
Drug: High-Ca group
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Ca group (600 mg of calcium per day)
Trial: 24844611
Drug: Low-Ca group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Ca group (300 mg of calcium per day)
Trial: 24844611
Drug: Mid-Ca group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mid-Ca group (300 mg of calcium per day)
Trial: 14559319
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg daily of Se as selenomethionine (SeMet) for 4 weeks
Trial: 10965636
Drug: Systemic-behavioral family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic-behavioral family therapy (SBFT)
Trial: 1479631
Drug: Substance abuse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance abuse treatment only
Trial: 1479631
Drug: Attention control
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Attention control group receiving treatment for substance abuse and training in progressive muscle relaxation
Trial: 6367665
Drug: Prazosin hydrochloride
RxNorm normalized name: Prazosin Hydrochloride
DrugBank: Prazosin (DB00457)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prazosin hydrochloride (1 mg orally three times a day)
Trial: 27468708
Drug: L-AGE diet
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AGE diet
Trial: 24456328
Drug: CERA (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CERA (continuous erythropoietin receptor activator)
Trial: 17337164
Drug: Duloxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine treatment for 7-14 days
Trial: 16255011
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day prednisolone
Trial: 23808255
Drug: Parenteral feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral feeding
Trial: 7493437
Drug: Cholecystokinin-8 infusion
RxNorm normalized name: cholecystokinin
DrugBank: Cholecystokinin (DB08862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecystokinin-8 infusion
Trial: 26089546
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C
Trial: 21517955
Drug: Prandial +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prandial + basal insulin
Trial: 19236501
Drug: Neuroaid (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroaid (4 capsules, 3 times daily for 3 months)
Trial: 19236501
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 capsules, 3 times daily for 3 months)
Trial: 12762431
Drug: Eradication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication treatment (ET group) with Lansoprazol 30 mg/day for three months
Trial: 12762431
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment (ST group) with Lansoprazol 30 mg/day for three months
Trial: 10175551
Drug: Manually operated
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manually operated metered dose inhaler (MDI)
Trial: 3767127
Drug: Albuterol (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (4.0 mg)
Trial: 9250445
Drug: Terbutaline (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5.0 mg)
Trial: 25091820
Drug: Aspirin (160mg/day)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (160mg/day) plus citalopram (20mg/day)
Trial: 18663300
Drug: Fluoridated dentifrice
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoridated dentifrice (twice per day)
Trial: 15363566
Drug: Dutasteride 0.5mg
RxNorm normalized name: DUTASTERIDE 0.5MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5mg daily (D/D group)
Trial: 15363566
Drug: Placebo followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo followed by Dutasteride 0.5mg daily (P/D group)
Trial: 9390608
Drug: Neostigmine 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 2.0 mg and glycopyrrolate 0.4 mg intravenously (Group A)
Trial: 9390608
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs to facilitate antagonism of blockade (Group B)
Trial: 22381771
Drug: TMZ-RT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMZ-RT group (60 Gy radiotherapy with concurrent temozolomide treatment)
Trial: 22381771
Drug: VM-RT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VM-RT group (60 Gy radiotherapy with concurrent VM-26 plus Me-CCNU treatments)
Trial: 10442154
Drug: Antioxidant supplement
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplement (20,000 IU beta-carotene, 400 IU vitamin E, 500 mg vitamin C, 100 micrograms selenium, 30 mg zinc)
Trial: 15467097
Drug: Antioxidant supplement
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplement
Trial: 8546287
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion (total dose 860 mg, range 540‐1520 mg)
Trial: 30922964
Drug: DPP-4 inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP-4 inhibitors (DPP-4i)
Trial: 30922964
Drug: α-glucosidase inhibitor
RxNorm normalized name: alpha glucosidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-glucosidase inhibitor (acarbose)
Trial: 27856001
Drug: Standard nutritional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard nutritional therapy (control)
Trial: 20025685
Drug: Neoral cyclosporine-based
RxNorm normalized name: cyclosporine Oral Capsule [Neoral]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral cyclosporine-based therapy
Trial: 11738537
Drug: quetiapine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine 600 mg/day
Trial: 17293709
Drug: quetiapine 300
RxNorm normalized name: quetiapine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine 300 mg/day
Trial: 15264726
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg x kg(‐1) pre‐induction bolus followed by intravenous infusion of ketamine 0.5 mg x kg(‐1) x h(‐1) for 72 hours
Trial: 15264726
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline) as pre‐induction bolus followed by normal saline infusion for 72 hours
Trial: 2890398
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml saline (control)
Trial: 27229707
Drug: IVB 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVB 1.25 mg
Trial: 27229707
Drug: IVB 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVB 1.25 mg with STA 40 mg
Trial: 24111757
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy in critically ill patients
Trial: 20855136
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of a fat emulsion (Calogen(®)) 3 times daily, providing 420 kcal
Trial: 10858989
Drug: IgE antibody
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgE antibody titers to ovalbumin
Trial: 1592884
Drug: 30 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms/kg oral GHRP
Trial: 1592884
Drug: 100 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms/kg oral GHRP
Trial: 1592884
Drug: 300 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 micrograms/kg oral GHRP
Trial: 6205052
Drug: 4 per
RxNorm normalized name: Flex24 Performance
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 per cent chlorhexidine-detergent solution
Trial: 6205052
Drug: Routine cord
RxNorm normalized name: Bos taurus umbilical cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine cord care with 4 per cent chlorhexidine-detergent solution
Trial: 2185825
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution (GS)
Trial: 15346704
Drug: Regrow 120
RxNorm normalized name: minoxidil
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Regrow 120 mg
Trial: 15346704
Drug: Regrow 240
RxNorm normalized name: minoxidil
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Regrow 240 mg
Trial: 11870795
Drug: Pulsed KTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed KTP laser treatment with aqueous gel
Trial: 11870795
Drug: Pulsed KTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed KTP laser treatment without aqueous gel
Trial: 8861460
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of uncooked cornstarch as part of the 21:00 evening snack
Trial: 2177746
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Org 2766 (synthetic analog of ACTH 4‐9)/day for 4 weeks
Trial: 6343148
Drug: Oral etretinate
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral etretinate (Tigason)
Trial: 25166761
Drug: Twice-daily placebo
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily placebo dentifrice
Trial: 25166761
Drug: Twice-daily fluoride
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily fluoride dentifrice
Trial: 25166761
Drug: Twice-daily fluoride
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily fluoride dentifrice and once-daily fluoride mouthrinse
Trial: 25166761
Drug: Thrice-daily fluoride
RxNorm normalized name: potassium nitrate / sodium fluoride Toothpaste [Fluoridex Daily Defense Sensitivity]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-daily fluoride dentifrice
Trial: 11710724
Drug: Colchicine (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1-2 mg/day, adjusted to body weight)
Trial: 2958783
Drug: Niaprazine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niaprazine (1.5 mg/kg/day)
Trial: 26453952
Drug: Nutritional therapy
RxNorm normalized name: nutritional therapy for GSD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional therapy (30‐35 kcal/kg/d, 1.0‐1.5 g vegetable protein/kg/d)
Trial: 26453952
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no nutritional therapy)
Trial: 10530967
Drug: Levodopa-carbidopa (2.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa-carbidopa (2.08 mg/kg of body weight)